Sumitomo Pharma Co., Ltd. (FRA:DPM)

Sumitomo Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 9, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	6,286	1,789	969	2,228	3,558	5,898
Market Cap Growth	323.78%	84.67%	-56.51%	-37.37%	-39.67%	25.11%
Enterprise Value	7,507	3,575	3,270	2,397	4,497	7,137
Last Close Price	16.20	4.52	2.38	5.45	8.55	13.91
PE Ratio	7.05	12.26	-	-	8.51	13.62
PS Ratio	2.45	0.73	0.50	0.58	0.86	1.48
PB Ratio	4.11	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	47.42	36.19	-	92.74	20.09	5.91
P/OCF Ratio	36.42	17.55	-	26.96	15.36	5.65
EV/Sales Ratio	3.10	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	9.94	15.00	-	-	6.17	12.04
EV/EBIT Ratio	11.85	44.43	-	-	10.12	17.06
EV/FCF Ratio	56.63	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	0.99	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	1.89	8.14	-	-	2.89	3.78
Debt / FCF Ratio	11.42	39.27	-	99.82	11.91	2.24
Asset Turnover	0.56	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.81	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.83	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.36	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	81.47%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	9.25%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Capital (ROIC)	14.15%	1.52%	-33.20%	-9.23%	3.95%	3.60%
Return on Capital Employed (ROCE)	20.20%	2.60%	-90.60%	-16.50%	5.80%	5.30%
Earnings Yield	14.17%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	2.11%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.67%	2.43%	1.55%
Payout Ratio	0.00%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.67%	2.43%	1.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.